This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Universal Health (UHS) Gains 3.7% as Pent-Up Surgeries Rise
by Zacks Equity Research
The pent-up demand for elective surgeries is expected to improve Universal Health's (UHS) patient admissions and patient days.
Company News for Jun 15, 2023
by Zacks Equity Research
Companies in The News Are: UNH, AMD, AMZN, UHS, DVN
Universal Health Services (UHS) Surges 3.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Universal Health Services (UHS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Investors Should Hold Universal Health (UHS) Now
by Zacks Equity Research
Universal Health (UHS) benefits from growing patient volumes, sound segmental performance and a solid capital position.
Universal Health Services (UHS) Down 10.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare's (THC) Q1 Earnings Beat, Shares Up 3.9%
by Zacks Equity Research
Tenet Healthcare's (THC) first-quarter 2023 results gain on increased patient volumes. Management presently expects adjusted EPS within $4.92-$6.09 in 2023, up from the prior view of $4.68-$5.85.
Universal Health (UHS) Q1 Earnings Beat on Higher Admissions
by Zacks Equity Research
Universal Health's (UHS) Q1 results reflect strong performance in acute care and behavioral health segments. Meanwhile, the elevated expense level partially offsets the positives.
Universal Health Services (UHS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 8.84% and 1.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Universal Health (UHS) to Release Q1 Earnings: Factors to Note
by Zacks Equity Research
Universal Health's (UHS) Q1 results are likely to benefit from higher patient volumes and solid demand for behavioral healthcare services. However, increased labor costs might partly offset the results.
Universal Health Services (UHS) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.
4 Stocks in Focus as Hospital Industry Witnesses Improvement
by Kaibalya Pravo Dey
Easing staffing challenges and technological adoption are aiding the margins of the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Acadia (ACHC) and Tenet Healthcare (THC) are poised to gain from improving volumes.
Why Is Universal Health Services (UHS) Down 7.4% Since Last Earnings Report?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Universal Health (UHS) Up 26% in 6 Months: More Room to Run?
by Zacks Equity Research
Universal Health (UHS) is well-poised for growth on the back of improved patient volumes, acquisitions and robust cash-generating abilities.
Universal Health (UHS) Q4 Earnings Beat on Solid Segments
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results indicate growing revenues in its segments resulting from higher patient volumes. Management expects adjusted EPS within $9.50-$10.50 for 2023.
Universal Health Services (UHS) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 2.03% and 1.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Universal Health (UHS) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results are likely to reflect an increase in same facility adjusted admissions in acute care hospitals.
Community Health Systems (CYH) Tops Q4 Earnings Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 265.85% and 0.89%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.
Investors Should Watch These 4 Hospital Stocks Despite Headwinds
by Kaibalya Pravo Dey
Rising costs amid inflationary pressures are trimming margins for the Zacks Medical-Hospital industry players. Yet, HCA Healthcare (HCA), Universal Health (UHS), Acadia Healthcare (ACHC) and Tenet Healthcare (THC) are poised to win big with improving volumes.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH